Challenging drug-resistant TB treatment journey for children, adolescents and their care-givers: A qualitative study

Das, Mrinalini and Mathur, Taanya and Ravi, Shilpa and Meneguim, Augusto C. and Iyer, Aparna and Mansoor, Homa and Kalon, Stobdan and Hossain, Farah Naz and Acharya, Shrikala and Ferlazzo, Gabriella and Isaakidis, Petros and Thakur, Harshad P. and Engel, Nora (2021) Challenging drug-resistant TB treatment journey for children, adolescents and their care-givers: A qualitative study. PLOS ONE, 16 (3). e0248408. ISSN 1932-6203

[thumbnail of journal.pone.0248408.pdf] Text
journal.pone.0248408.pdf - Published Version

Download (1MB)

Abstract

Background
Childhood multidrug-resistant TB (MDR-TB) still affects around 25000 children every year across the globe. Though the treatment success rates for drug-resistant TB (DR-TB) in children are better than adults, children and adolescents face unique hurdles during DR-TB (MDR-TB, Pre-XDR TB and XDR-TB) treatment. This study aimed to understand the patients, guardians and healthcare providers’ perspectives about DR-TB treatment journey of patients and caregivers.

Methods
This is a qualitative study involving in depth-interviews of purposively selected adolescents (n = 6), patients guardians (for children and adolescents, n = 5) and health care providers (n = 8) of Médecins Sans Frontières (MSF) clinic, Mumbai, India. In-depth face to face interviews were conducted in English or Hindi language using interview guides during September-November 2019. The interviews were audio-recorded after consent. Thematic network analysis was used to summarize textual data. ATLAS.ti (version 7) was used for analysis.

Result
The age of adolescent patients ranged from 15–19 years and four were female. Five guardians (of three child and two adolescent patients) and eight healthcare providers (including clinicians- 2, DOT providers-2, counselors-2 and programme managers-2) were interviewed. The overarching theme of the analysis was: Challenging DR-TB treatment journey which consisted of four sub-themes: 1) physical-trauma, 2) emotional-trauma, 3) unavailable social-support and 4) non-adapted healthcare services. Difficulties in compounding of drugs were noted for children while adolescents shared experiences around disruption in social life due to disease and treatment. Most of the patients and caregivers experienced treatment fatigue and burnout during the DR-TB treatment. Participants during interviews gave recommendations to improve care.

Discussion
The TB programmes must consider the patient and family as one unit when designing the package of care for paediatric DR-TB. Child and adolescent friendly services (paediatric-formulations, age-specific counselling tools and regular interaction with patients and caregivers) will help minimizing burnout in patients and caregivers.

Item Type: Article
Subjects: Impact Archive > Medical Science
Depositing User: Managing Editor
Date Deposited: 08 Feb 2023 05:06
Last Modified: 26 Jul 2024 06:24
URI: http://research.sdpublishers.net/id/eprint/642

Actions (login required)

View Item
View Item